Rentech Ltd company a biotech company, is expected to grow rapidly in the next three years and then have a level growth rate for the foreseeable future. The company expects free cash flows of $379.5 million, $545.1 million, and $794.3 million over the next three years, and thereafter its cash flows will grow at a steady rate of 3 percent per annum. The company has no non-operating assets (NOA). If the appropriate WACC is 12.06 percent, what is the enterprise value of this business?